Loading...
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer
BACKGROUND: Non-small cell lung cancers (NSCLC) account for 85–90% of all lung cancers. As drug resistance critically impairs chemotherapy effectiveness, there is great need to identify new therapeutic targets. The aims of this study were to investigate the prognostic and therapeutic potential of th...
Na minha lista:
| Udgivet i: | Br J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434762/ https://ncbi.nlm.nih.gov/pubmed/32439936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0899-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|